Latest News About Frampton

Here are the latest updates I can share about Frampton (Peter Frampton or Framptons) based on publicly available information up to now:

• Peter Frampton updates:

  • Peter Frampton has continued to perform in recent years despite his diagnosed inclusion-body myositis (IBM), often performing seated and adapting his shows to his condition. This ongoing activity has included special anniversary events and appearances around 2024–2025, with reports noting continued touring as well as ceremonial/televised events tied to his classic albums.[3][4]
  • In late 2025, coverage highlighted ongoing concerts and events commemorating Frampton Comes Alive! and related projects, with the artist continuing to engage in tours and appearances while managing IBM.[4][9]
  • His official touring and appearances sometimes feature seated performances, reflecting his health considerations, and media pieces across 2019–2025 have repeatedly discussed this adaptation to his live shows.[3][4]

• Framptons (plant-based co-packing company) updates:

  • Framptons, a plant-based co-packer known for oat drinks and related co-packing for brands, has experienced a notable corporate turnaround driven by strategic refocusing, cost controls, and leadership changes following investment activity. Publicly reported accounts in 2023–2024 show profitability returning after prior losses and a shift toward core products such as oat milks and the UK-based branding initiative The Wessex Oat Company.[1]
  • The business undertook significant workforce reductions and asset rationalization to regain competitiveness, with management citing debt repayment and consolidation as part of the recovery narrative. These developments point to a leaner operation focused on higher-margin activities and selective divestments of lower-margin lines.[1]
  • Since the investment from Profura (a Swedish investment fund) in late 2023, Framptons has emphasized refocusing on its core co-packing services and building out its own-brand oat drinks while winding down some non-core product lines, including some edible egg products that were sold to focus the business on higher-potential categories.[1]

If you’d like, I can narrow this down to:

• A quick snapshot of Peter Frampton’s current touring schedule and health updates.
• A concise timeline of Framptons’ major strategic moves and current product focus.

Would you prefer a brief, bullet-point chronology for either topic or a side-by-side comparison in a small table? I can also pull in more recent sources if you want the very latest.